Home/Filings/4/0000929638-23-003300
4//SEC Filing

Baron Caryl 4

Accession 0000929638-23-003300

CIK 0001831868other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 4:14 PM ET

Size

12.0 KB

Accession

0000929638-23-003300

Insider Transaction Report

Form 4
Period: 2023-09-22
Baron Caryl
Interim CFO
Transactions
  • Other

    Common Stock, par value $0.0001 per share

    2023-09-22+15,070119,579 total
  • Award

    Common Stock, par value $0.0001 per share

    2023-11-29+20,293139,872 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $1.84Exp: 2033-04-06Common Stock (16,621 underlying)
    16,621
  • Stock Option (Right to Buy)

    Exercise: $0.55Exp: 2031-01-01Common Stock (19,685 underlying)
    19,685
  • Stock Option (Right to Buy)

    Exercise: $10.00Exp: 2030-03-20Common Stock (4,796 underlying)
    4,796
Footnotes (6)
  • [F1]Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. The securities reported in this transaction were initially withheld by the Issuer to satisfy tax withholding obligations. The Issuer subsequently elected to satisfy the withholding obligations through an alternative method and returned these shares to the Reporting Person.
  • [F2]Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4.
  • [F3]The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.
  • [F4]All options reported herein will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant.
  • [F5]The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from March 30, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from March 30, 2021.
  • [F6]The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from January 1, 2021 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 1, 2022.

Documents

1 file

Issuer

SeaStar Medical Holding Corp

CIK 0001831868

Entity typeother

Related Parties

1
  • filerCIK 0001949735

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 4:14 PM ET
Size
12.0 KB